Alfonso Valverde-Garcia
Barcelona, CT 08035, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Preclinical study of microphthalmia-associated transcription factor inhibitor ML329 in gastrointestinal stromal tumor growth.
Journal: Molecular therapy. Oncology
Published: August 27, 2024
The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth.
Journal: Cancer gene therapy
Published: June 15, 2022
Emerging drugs for the treatment of gastrointestinal stromal tumors.
Journal: Expert opinion on emerging drugs
Published: March 01, 2021
Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time?
Journal: Current treatment options in oncology
Published: January 18, 2021
Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis.
Journal: Molecular cancer therapeutics
Published: September 22, 2020
Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor.
Journal: Molecular cancer therapeutics
Published: November 20, 2019
Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.
Journal: Molecular oncology
Published: April 05, 2018
Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors.
Journal: Targeted oncology
Published: May 08, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026